Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population (NCT04420091) | Clinical Trial Compass
CompletedNot Applicable
Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population
Belgium32 participantsStarted 2020-06-11
Plain-language summary
This study is an exploratory, non-comparative, multi-centric trial in 30 free-living healthy male and female subjects with moderate knee joint discomfort and loss of functionality.
The objective of this trial is to determine whether oral administration of Cartidyss, a concentrated fish cartilage extract, can contribute to the improvement of knee joint functionality and discomfort in adult population
Who can participate
Age range40 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female
* Age limits (see above)
* Body Mass Index BMI ≤ 35 kg/m2
* Knee discomfort score at rest over the last 24 hours on the most painful knee evaluated on VAS (0-100) ≥ 40 at baseline
* Able to follow the instructions of the study
* Having signed an informed consent
Exclusion Criteria:
* related to knee:
* Recent trauma (\< 1 month) of the knee responsible of the symptomatic knee;
* Concurrent articular disease interfering with the evaluation of knee pain left to the Investigator's discretion
* Prosthesis in the target knee
* related to treatments:
* Analgesics to manage knee pain 24 hours before inclusion visit;
* Corticosteroids injection in the target knee in the last month;
* Hyaluronan injection in the target knee in the last 6 months;
* Arthroscopy in the last 6 months
* Oral corticotherapy ≥ 5mg/day (in Prednisolone equivalent) in the last 3 months;
* Symptomatic slow-acting drugs for osteoarthritis (SYSADOA) or dietary supplement, i.e., curcuma extract, chondroitin, glucosamine, diacerein or avocado-soya unsaponifiables int he last 3 months
* Contraindications to Cartidyss: hypersensitivity or allergy to the product components (fish)
* Treatments based on strontium ranelate, bisphosphonates, selective estrogen-receptor modulator (SERM) and parathormone (PTH) in the last 12 months
* related to associated diseases :
* Any severe, uncontrolled and limiting diseases left to the Investigator's discretion
* An…
What they're measuring
1
Evaluate the effect of Cartidyss on knee functionality and discomfort after 3 months of supplementation